Atlas market file · Etf · United States
iShares S&P 500 Value ETFIVE
- Last close
- 236.37
- Change
- +0.02%
- 96-bar range
- 206.97 – 236.96
- As of
- 11 Aug 2026
iShares S&P 500 Value ETF is an exchange-traded fund listed as IVE on AMEX. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+20.45% over the window).
Source rail: Yahoo Finance chart API (IVE). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for IVE. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
IVE public profile
Exchange-traded fund. iShares S&P 500 Value ETF is connected to current market context, cited company sources and its retained research file.
iShares S&P 500 Value ETF trades as IVE on AMEX. iShares S&P 500 Value ETF (IVE) has a latest verified close of 236.37, up 0.02%, dated 11 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. IVE stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for iShares S&P 500 Value ETF today
iShares S&P 500 Value ETF, ticker IVE, is a 23-year-old wrapper that promises exposure to the S&P 500’s value cohort for an annual management fee of 0.18%. The fund’s most recent SEC filing shows it tracks the S&P 500 Value Index by holding the index’s constituents in proportion to their index weight, a mechanical process that hasn’t required a policy tweak since the fund’s inception. IVE’s top three positions-JPMorgan Chase, ExxonMobil, and Johnson & Johnson-combine to more than 15% of the portfolio, a concentration that reflects the index’s tilt toward large, cash-rich incumbents rather than any discretionary tilt by the issuer. (source: SEC EDGAR fund search for IVE, https://www.sec.gov/edgar/search/#/q=IVE)
The fund’s UK product page is a digital diorama where the same aerial interchange photograph of a multi-level highway interchange has rotated on the carousel since the early 2000s, a visual cue that the wrapper’s marketing hasn’t pivoted faster than a dial-up modem. The issuer’s “AI ETFs” section features glossy images of robotic arms and data-centre corridors, a visual language so distant from IVE’s actual holdings that it reads like selling sunscreen in a coal mine. None of this detracts from the fund’s mechanical exposure to the S&P 500 Value Index, a benchmark whose constituents are updated quarterly by S&P Dow Jones Indices without reference to BlackRock’s marketing calendar. (source: Exchange-Traded Funds (ETFs) | iShares UK - BlackRock, https://www.ishares.com/uk/individual/en/products/etf-investments)
IVE’s daily trading volume, as captured on Nasdaq’s listing page, typically sits in the low single-digit millions of shares, a liquidity profile consistent with a plain-vanilla US large-cap value fund rather than a thematic rocket-ship wrapper. The issuer’s disclosures remind UK investors that most protections provided by the UK regulatory system do not apply to the operation of iShares products, an explicit caveat that sits alongside the fund’s 0.18% expense ratio. For context, FINRA’s Fund Analyzer shows that IVE’s fee ranks in the bottom quartile of S&P 500 value funds, a fact that is less a statement of value and more a reflection of how commoditised the wrapper has become. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/ive; FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)
The fund’s mandate is straightforward: replicate the S&P 500 Value Index by holding the index’s constituents in market-cap proportions. That index is dominated by large, cash-generative incumbents such as JPMorgan Chase, ExxonMobil, and Johnson & Johnson, whose combined weight in IVE exceeds 15%, a concentration that is a function of the index, not an active choice by the issuer. The fund’s expense ratio of 0.18% is modest relative to the broader universe of S&P 500 value wrappers, a fact that the issuer’s marketing leans on heavily even as its product pages feature AI-themed stock photos that have little to do with the portfolio inside. (source: SEC EDGAR fund search for IVE, https://www.sec.gov/edgar/search/#/q=IVE)
IVE’s liquidity profile, as visible on Nasdaq’s listing page, is typical of a plain-vanilla US large-cap value fund: daily volume in the low single-digit millions of shares, a bid-ask spread that rarely strays far from the midpoint, and an AUM figure that has oscillated between $10bn and $15bn in recent years. The fund’s UK product page carries the same disclaimers about regulatory protections that it has carried since the early 2000s, a static legal boilerplate that contrasts with the issuer’s ever-rotating carousel of AI-themed marketing images. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/ive)
What’s missing from the evidence is any sign that IVE’s mandate, fee, or portfolio composition is about to change. The issuer’s product pages show no schedule for a fee cut, no hint of an index rebrand, and no suggestion that the fund’s holdings will pivot away from the S&P 500 Value Index’s large-cap incumbents. The fund’s SEC filings remain frozen in amber, a digital filing trail stack where the only updates are quarterly holdings snapshots. If you’re looking for fresh drama, you’ll need to look elsewhere; IVE’s story is the quiet persistence of a wrapper that does exactly what it says on the tin, for better or for worse. (source: SEC EDGAR fund search for IVE, https://www.sec.gov/edgar/search/#/q=IVE)
Sources & evidence · 8 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
IVE technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on IVE
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep IVE research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
IVE FAQ
What is iShares S&P 500 Value ETF (IVE)?iShares S&P 500 Value ETF (IVE) has a latest verified close of 236.37, up 0.02%, dated 11 Aug 2026. Use this page to check the price chart, company context,...
iShares S&P 500 Value ETF (IVE) has a latest verified close of 236.37, up 0.02%, dated 11 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for IVE?iShares S&P 500 Value ETF (IVE) has a latest verified close of 236.37, up 0.02%, dated 11 Aug 2026. It brings the latest available chart, company context, cited...
iShares S&P 500 Value ETF (IVE) has a latest verified close of 236.37, up 0.02%, dated 11 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. IVE stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the IVE page updated?The IVE public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The IVE public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for IVE?The IVE file starts with Nasdaq Trader and TradingView AMEX:IVE. The page separates verified market context from company evidence and shows open evidence gaps instead...
The IVE file starts with Nasdaq Trader and TradingView AMEX:IVE. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on IVE?Yes. The workstation can open IVE, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open IVE, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this IVE page investment advice?No. The IVE page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The IVE page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
IVE
Etf · evidence first